Editing anti-DNA B cells by Vlambdax.

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Receptor editing is a key mechanism for B cell tolerance, involving Vkappa gene replacement or Ckappa locus deletion.
• B cells deleting Ckappa can express lambda light chains, but the lambda locus lacks V gene replacement or deletion mechanisms.
• Autoreactive B cells expressing lambda light chains may require alternative pathways for tolerance induction.

Purpose of the Study:

• To investigate mechanisms preventing DNA binding in autoreactive B cells expressing lambda light chains.
• To identify alternative pathways for tolerance induction in B cells that cannot undergo conventional light chain editing.

Main Methods:

• Analysis of anti-DNA heavy chain transgenic mice (VH3H9/56R).
• Characterization of B cells coexpressing lambda1 and kappa chains.
• Identification and analysis of B cells expressing the Vlambdax light chain.

Main Results:

• In anti-DNA transgenic mice, B cells with anti-DNA receptors often coexpress a kappa chain that inhibits DNA binding.
• A rare Vlambda family member, Vlambdax, was identified as a mechanism to prevent DNA binding in B cells.
• B cells expressing Vlambdax also express CD25, suggesting they may have exhausted conventional light chain editing options.

Conclusions:

• Expression of Vlambdax represents a novel pathway for preventing DNA binding and inducing tolerance in autoreactive B cells.
• CD25 expression on Vlambdax+ B cells may indicate a terminal stage of light chain editing.
• These findings shed light on alternative B cell tolerance mechanisms beyond V gene replacement.